Pacific Biosciences of California Inc
NASDAQ:PACB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Pacific Biosciences of California Inc
NASDAQ:PACB
|
US |
|
Svenska Cellulosa SCA AB
LSE:0MCK
|
SE |
|
Intellect Design Arena Ltd
NSE:INTELLECT
|
IN |
|
D
|
Deutsche Telekom AG
F:DTE
|
DE |
|
W
|
Weyerhaeuser Co
F:WHC
|
US |
|
Fleury Michon SA
PAR:ALFLE
|
FR |
|
Vicinity Centres
ASX:VCX
|
AU |
|
Allbirds Inc
NASDAQ:BIRD
|
US |
|
Mind Medicine (MindMed) Inc
F:MMQ
|
US |
|
Q
|
QL Resources Bhd
KLSE:QL
|
MY |
|
Lar Espana Real Estate SOCIMI SA
MAD:LRE
|
ES |
|
M
|
Mitsubishi Gas Chemical Co Inc
XBER:MUG
|
JP |
|
Nordic American Tanker Ltd
NYSE:NAT
|
BM |
|
Freeport-McMoRan Inc
NYSE:FCX
|
US |
|
V
|
Verbund AG
VSE:VER
|
AT |
|
Iris Energy Ltd
NASDAQ:IREN
|
AU |
|
VGP NV
OTC:VGPBF
|
BE |
|
Entergy Corp
NYSE:ETR
|
US |
|
ALM Equity AB
F:I53
|
SE |
|
V
|
VGI PCL
SET:VGI
|
TH |
Wall St Price Targets
PACB Price Targets Summary
Pacific Biosciences of California Inc
According to Wall Street analysts, the average 1-year price target for
PACB is 2.51 USD with a low forecast of 1.52 USD and a high forecast of 3.15 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PACB's stock price target?
Price Target
2.51
USD
According to Wall Street analysts, the average 1-year price target for
PACB is 2.51 USD with a low forecast of 1.52 USD and a high forecast of 3.15 USD.
What is the Revenue forecast for Pacific Biosciences of California Inc?
Projected CAGR
22%
Over the last 13 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 7 years is 22%.